Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
about
The significance of genetics for cholangiocarcinoma developmentExperimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.4-Phenylbutyrate attenuates the ER stress response and cyclic AMP accumulation in DYT1 dystonia cell models.The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1.Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells through alternative splicing of c-MplInhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach.Current evidence for histone deacetylase inhibitors in pancreatic cancer.Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials?Chromatin, cancer and drug therapies.The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response.Recent advances in the development of polyamine analogues as antitumor agents.Use of polyamine derivatives as selective histone deacetylase inhibitors.Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors.Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation.Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells.Polyamine-based small molecule epigenetic modulators.mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.
P2860
Q26865749-EB98E9A2-C797-485A-A900-D5D98436722CQ34297701-84DA55CD-CF30-4037-B6C5-4BD6EAE177CCQ34472800-DB2C9426-046A-41BD-9BED-7E7615281878Q34674274-B218DEB2-5F11-4FB6-938E-EBB2E61F09ABQ35056295-D1C73816-78B7-46E2-90A6-9B7D8842A5CDQ36177918-CFF39D5A-4154-441E-B91A-56C73E47E06EQ36616790-E8A7DA53-9EE8-414F-9A0B-D11102B57710Q36654454-0F65BECF-0F56-44AC-9ABE-AEA1EE1C4F66Q37073231-E95ACD29-DE5E-40DB-B9B1-A7C55563947DQ37430626-73A9E843-D8D5-42E5-A730-A30D321F762AQ37522449-7C7F0603-D5F4-4C43-9A93-CD6738D8F38CQ39592778-FE38A213-3CD0-4486-AD09-1CBCB2986424Q40001178-2516DC7E-3974-4C2F-860B-962E140170A9Q40310696-C99201F1-AED9-4D39-9CD7-A8A4553D6B2DQ41807496-CDD9FD43-4DF8-4E18-9A50-FE8723D1951FQ41911402-0EDADF88-C2B3-4108-B842-1434B4421EDFQ41912848-A39F80B4-7D58-4F9A-88DD-3303A1975658Q42709676-A0D6E9F8-CB7C-434F-9607-ED89FEEB8E82
P2860
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
@ast
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
@en
type
label
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
@ast
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
@en
prefLabel
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
@ast
Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
@en
P1433
P1476
Histone deacetylase inhibitors: a novel target of anticancer therapy (review)
@en
P2093
Gregory Kouraklis
Stamos Theocharis
P304
P577
2006-02-01T00:00:00Z